Bosentan 62.5 mg/1 (Bosentan TABLET, FILM COATED) 62.5 mg/1

Bosentan 62.5 mg tablets are an oral medication used to manage certain conditions related to blood vessel function. This film-coated tablet is manufactured by Actavis Pharma, Inc. in the USA.

Strength

62.5 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0591-2511-60)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bosentan is primarily used to treat conditions involving the narrowing of blood vessels. It works by relaxing these vessels to improve blood flow. People often ask, 'What is bosentan used for?' and the answer typically involves its role in managing pulmonary arterial hypertension and other related vascular issues.

Side Effects

Common effects of bosentan may include headaches, flushing, and swelling in the legs or ankles. Some users also report experiencing dizziness or nausea. These effects can vary from person to person.

Precautions & Warnings

Bosentan should be handled with care, especially for those with liver problems. Regular monitoring of liver function is often recommended. It is important to follow the advice of a healthcare provider regarding its use.

Avoid Interactions

Bosentan may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to consult a healthcare provider before combining bosentan with other medications, especially those known to affect liver enzymes.

Frequently Asked Questions

Bosentan is used to treat conditions involving the narrowing of blood vessels, such as pulmonary arterial hypertension.

Bosentan is typically taken orally, as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions.

Common side effects may include headaches, flushing, swelling in the legs or ankles, dizziness, and nausea.

Bosentan may interact with other medications, especially those metabolized by the liver. Consult a healthcare provider before combining bosentan with other drugs.

Individuals with liver problems or those taking certain medications should exercise caution with bosentan. Always consult a healthcare provider before starting this medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.